ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1111

SGLT2 Inhibition Ameliorates Age-Dependent Renovascular Rarefaction

Session Information

  • Geriatric Nephrology
    November 08, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Geriatric Nephrology

  • 1300 Geriatric Nephrology

Authors

  • Paulmann, Anastasia, Medizinische Hochschule Hannover, Hanover, NDS, Germany
  • Cox, Matthew, Mount Desert Island Biological Laboratory, Salsbury Cove, Maine, United States
  • Boewer, Tom Jannek, Medizinische Hochschule Hannover, Hanover, NDS, Germany
  • Somers, Hannah, Mount Desert Island Biological Laboratory, Salsbury Cove, Maine, United States
  • Fuqua, Jeremy Heath, Mount Desert Island Biological Laboratory, Salsbury Cove, Maine, United States
  • Seaman, Ryan P, Mount Desert Island Biological Laboratory, Salsbury Cove, Maine, United States
  • Graber, Joel H, Mount Desert Island Biological Laboratory, Salsbury Cove, Maine, United States
  • Mahajan, Anchal, Colby College, Waterville, Maine, United States
  • Johnson, Cory P., Mount Desert Island Biological Laboratory, Salsbury Cove, Maine, United States
  • Beverly-Staggs, Laura L., Mount Desert Island Biological Laboratory, Salsbury Cove, Maine, United States
  • Sandhi, Sonia, Medizinische Hochschule Hannover, Hanover, NDS, Germany
  • Schenk, Heiko Joachim, Medizinische Hochschule Hannover, Hanover, NDS, Germany
  • Haller, Hermann, Medizinische Hochschule Hannover, Hanover, NDS, Germany
Background

Aging is associated with progressive loss of renal function and vascular structure, with and without chronic kidney disease. However, the mechanisms driving renal vascular aging and potential therapeutic interventions remain poorly understood.

Methods

To model this state-of-affairs, we used African turquoise killifish (Nothobranchius furzeri), a naturally short-lived vertebrate. We then inhibited the sodium-glucose co-transporter 2 inhibition (SGLT2i) to test a potential therapeutic intervention. Histological, immunofluorescent, and 3D vascular imaging were used to evaluate glomerular, tubular, and vascular changes. Single-nuclei transcriptomic profiling was performed on whole kidneys to identify age- and treatment-associated molecular signatures.

Results

Aged killifish kidneys exhibited hallmark features of human renal aging, including glomerulosclerosis, tubular fibrosis, and vascular rarefaction. Functional changes included increased proteinuria and altered tubular transporter expression. Transcriptomic profiling revealed a metabolic shift from oxidative phosphorylation to glycolysis and upregulation of pro-inflammatory pathways. Aged vasculature also displayed a marked reduction in tight junctions and cell–cell contacts. Dapagliflozin attenuated age-related vascular rarefaction, preserved functional peritubular capillary networks, and reduced albuminuria by restoring a youthful transcriptional profile and enhancing intercellular signaling. However, fish lifespan was not extended.

Conclusion

This study establishes the killifish as a translational model for investigating renal vascular aging. We show that SGLT2i preserves renal microvascular structure and function, reduces proteinuria, and reprograms the aged transcriptome. These results support a vascular-protective role of SGLT2i in mitigating age-related renal deterioration.

Funding

  • Other NIH Support – AstraZeneca

Digital Object Identifier (DOI)